PATENT CLAIM ANALYSIS

Application Number: 15872750
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "144100"]

Abstract:
The present invention relates to an attenuated mutant strain of  Salmonella  comprising a recombinant DNA molecule encoding Wilms' tumor Protein I. In particular, the present invention relates to the use of said attenuated mutant strain of  Salmonella  in cancer immunotherapy.

Claim (Index 19):
The method of  claim 18 , wherein said one or more further attenuated mutant strain(s) of  Salmonella  comprise(s) an attenuated mutant strain of  Salmonella  encoding human VEGFR-2.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 86.0
- Lexical Diversity: 1.375
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15785743', '14409434', '14366186', '14888831', '11840928']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6055619086523558
- 35 USC 102 Novelty (BERT): 0.546280292189947
- Combined Prediction Score: 0.5996337470061149
- Mean Citation Score: 313.98233
- Max Citation Score: 411.2976
- Similarity Product: 287.2484872146606

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test